Tatman, P.D.; Wroblewski, T.H.; Fringuello, A.R.; Scherer, S.R.; Foreman, W.B.; Damek, D.M.; Lillehei, K.; Youssef, A.S.; Jensen, R.L.; Graner, M.W.;
et al. High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas. J. Clin. Med. 2021, 10, 3150.
https://doi.org/10.3390/jcm10143150
AMA Style
Tatman PD, Wroblewski TH, Fringuello AR, Scherer SR, Foreman WB, Damek DM, Lillehei K, Youssef AS, Jensen RL, Graner MW,
et al. High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas. Journal of Clinical Medicine. 2021; 10(14):3150.
https://doi.org/10.3390/jcm10143150
Chicago/Turabian Style
Tatman, Philip D., Tadeusz H. Wroblewski, Anthony R. Fringuello, Samuel R. Scherer, William B. Foreman, Denise M. Damek, Kevin Lillehei, A. Samy Youssef, Randy L. Jensen, Michael W. Graner,
and et al. 2021. "High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas" Journal of Clinical Medicine 10, no. 14: 3150.
https://doi.org/10.3390/jcm10143150
APA Style
Tatman, P. D., Wroblewski, T. H., Fringuello, A. R., Scherer, S. R., Foreman, W. B., Damek, D. M., Lillehei, K., Youssef, A. S., Jensen, R. L., Graner, M. W., & Ormond, D. R.
(2021). High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas. Journal of Clinical Medicine, 10(14), 3150.
https://doi.org/10.3390/jcm10143150